Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.53 |
| ▸ | SLC6A3 known ✓ | Q01959 | 2/20 | 0.53 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.53 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.53 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.53 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 2/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.53 |
| ▸ | TACR2 | P21452 | 2/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | SHBG | P04278 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11193237 | 1.00 | HTR2A (0.59) | HTR2AESR1ADRA2AADORA3TACR2 | |
| Hydrochloric Acid SCHEMBL10716225 | 1.00 | HTR2A (0.59) | HTR2AESR1ADRA2AADORA3TACR2 | |
| Hydrochloric Acid SCHEMBL11428130 | 1.00 | HTR2A (0.59) | HTR2AESR1ADRA2AADORA3TACR2 | |
| SCHEMBL5299310 | 0.98 | HTR2A (0.61) | HTR2AESR1ADRA2AADORA3TACR2 | |
| SCHEMBL5304765 | 0.98 | HTR2A (0.61) | HTR2AESR1ADRA2AADORA3TACR2 | |
| SCHEMBL5305758 | 0.98 | HTR2A (0.61) | HTR2AESR1ADRA2AADORA3TACR2 | |
| SCHEMBL5303025 | 0.98 | HTR2A (0.61) | HTR2AESR1ADRA2AADORA3TACR2 | |
| SCHEMBL5815570 | 0.98 | HTR2A (0.61) | HTR2AESR1ADRA2AADORA3TACR2 | |
| SCHEMBL10645352 | 0.98 | HTR2A (0.61) | HTR2AESR1ADRA2AADORA3TACR2 | |
| SCHEMBL5299368 | 0.98 | HTR2A (0.61) | HTR2AESR1ADRA2AADORA3TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5143917-A | Cationic tensides for controlling infections | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-09-01 | — | — | US | disclosed |
| US-5133973-A | Quaternary Ammonium Cationic Surfactants, Antimetabolites | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-07-28 | — | — | US | disclosed |
| US-5118808-A | Pharmaceutical preparations | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-06-02 | — | — | US | disclosed |
| US-5112844-A | Micelles | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-05-12 | — | — | US | disclosed |
| US-5110929-A | Quaternization of pyrazine compounds | MEDICE CHAM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-05-05 | — | — | US | disclosed |
| US-5057518-A | Substituted n-alkylpyrimidinium salts for absorbing hydrophobic drugs | MEDICE HEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1991-10-15 | — | — | US | disclosed |
| US-5051435-A | Micelles of triazolium compounds as cationic surfactants | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1991-09-24 | — | — | US | disclosed |
| US-5045530-A | Conprising a micelle or a vesicle of a cationic teniside based on a hydrophobic alkyl-substituted pyridinium compound and a hydrophobic drug; drug delivery; skin disorders | MEDICI CHEM.-PHARM. FABRIK PUTTER GMBH (DE) | 1991-09-03 | — | — | US | disclosed |
| US-4999435-A | Cationic Surfactants, Drugs, Immunoassay | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1991-03-12 | — | — | US | disclosed |
| US-4965357-A | CATIONIC TENSIDES, ANTIMETABOLITES | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1990-10-23 | — | — | US | disclosed |
| US-4894454-A | BACTERICIDES | MEDICE CHEM.-PHARM. FABRIK, PUTTER GMBH & CO., KG (DE) | 1990-01-16 | — | — | US | disclosed |
| US-4882435-A | CATIONIC TENSIDES; THIADIAZOLIUM SALTS | MEDICE CHEM.-PHARM. FABRIK (DE) | 1989-11-21 | — | — | US | disclosed |
| US-4877883-A | CATIONIC SURFACTANTS | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1989-10-31 | — | — | US | disclosed |
| US-4874850-A | CATIONIC TENSIDES IN MICELLES WITH HYDROPHOBIC PEPTIDES; DRUG DELIVERY | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. (DE) | 1989-10-17 | — | — | US | disclosed |
| US-4870174-A | CATIONIC SURFACTANTS, SMALL CRITICAL MICELLE CONCENTRATIONS | MEDICE CHEM.-PHARM. FABRIK (DE) | 1989-09-26 | — | — | US | disclosed |